摘要
多囊卵巢综合征(PCOS)是一种常见的内分泌紊乱性疾病,常发生在育龄期女性中。PCOS可以引起排卵障碍、卵巢多囊样改变等,是女性不孕的主要原因之一,严重影响女性的生殖健康。PCOS患者主要通过促排卵治疗,而对于反复促排卵失败的患者,往往需要辅助生殖技术助孕治疗。黄体生成素(LH)可以调节卵泡发育,促进卵子成熟,是衡量卵巢功能的重要指标。现就LH在PCOS患者行体外受精–胚胎移植(IVF-ET)中的应用作一综述。
Polycystic ovary syndrome (PCOS) is a common endocrine disorder that often occurs in women of reproductive age. PCOS can cause ovulation disorder and polycystic ovary change, which is one of the main causes of female infertility and seriously affects female reproductive health. PCOS patients are mainly treated by ovulation induction, and for patients with repeated ovulation failure, assisted reproductive technology is often needed to assist pregnancy treatment. Luteinizing hormone (LH) can regulate follicle development, promote egg maturation, and is an important indicator of ovarian function. This article reviews the application of LH in vitro fertilization-embryo transfer (IVF-ET) in PCOS patients.
出处
《临床医学进展》
2024年第3期354-359,共6页
Advances in Clinical Medicine
